𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy and safety of saxagliptin in combination with metformin compared with sitagliptin in combination with metformin in adult patients with type 2 diabetes mellitus

✍ Scribed by André J. Scheen; Guillaume Charpentier; Carl Johan Östgren; Åsa Hellqvist; Ingrid Gause-Nilsson

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
237 KB
Volume
26
Category
Article
ISSN
1520-7552

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of rosiglitazone plu
Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes
✍ Francisco J. Gómez-Perez; Guillermo Fanghänel-Salmón; Juan Antonio Barbosa; Juan 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

## Abstract ## Background Type 2 diabetes is a growing problem in Mexico. The present study was undertaken to evaluate the efficacy and safety of rosiglitazone 2 mg or 4 mg twice daily (bd) in combination with metformin 2.5 g/day in Mexican patients whose type 2 diabetes was inadequately controlle

Three-year mortality in diabetic patient
Three-year mortality in diabetic patients treated with different combinations of insulin secretagogues and metformin
✍ Matteo Monami; Chiara Luzzi; Caterina Lamanna; Veronica Chiasserini; Filomena Ad 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 127 KB

## Abstract ## Background Several studies have shown an increase of mortality in diabetic patients treated with combinations of sulphonylureas and biguanides. Comparisons between different insulin secretagogues in combination with metformin with respect to all‐cause mortality have not been reporte

Reversal of increased lymphocyte PC-1 ac
Reversal of increased lymphocyte PC-1 activity in patients with Type 2 diabetes treated with metformin
✍ Vladisav Stefanović; Slobodan Antić; Marina Mitić-Zlatković; Predrag Vlahović 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Background: The plasma cell differentiation antigen (pc-1) is an inhibitor of insulin receptor tyrosine kinase activity, and has been implicated in the pathogenesis of insulin resistance in type 2 diabetes. metformin increases peripheral insulin sensitivity and, therefore, we have studied the ef